![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 9, 8086-8093, March 4, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Induction by CpG-A in Plasmacytoid Dendritic Cells*











¶¶
From the
Department of Internal Medicine, Division of Clinical Pharmacology, Ludwig-Maximilians-University of Munich, 80336 Muenchen, Germany, ¶Department of Geo- and Environment Sciences, Ludwig-Maximilians-University of Munich, 80333 Muenchen, Germany, **Institute of Immunology, Ludwig-Maximilians-University of Munich, 80336 Muenchen, Germany, 
CureVac GmbH, 72076 Tuebingen, Germany, and 
Research Center for Nucleic Acid and Peptide Chemistry, University of Tuebingen, 72076 Tuebingen, Germany
Plasmacytoid dendritic cells (PDC) represent a highly specialized immune cell subset that produces large quantities of the anti-viral cytokines type I interferons (IFN-
and IFN-
) upon viral infection. PDC employ a member of the family of toll-like receptors, TLR9, to detect CpG motifs (unmethylated CG dinucleotides in certain base context) present in viral DNA. A certain group of CpG motif-containing oligodeoxynucleotides (CpG ODN), CpG-A, was the first synthetic stimulus available that induced large amounts of interferon-
(IFN-
) in PDC. However, the mechanism responsible for this activity remained elusive. CpG-A is characterized by a central palindrome and poly(G) at the 5' and 3' end. Here we demonstrate that CpG-A self-assembles to higher order tertiary structures via G-tetrad formation of their poly(G) motifs. Spontaneous G-tetrad formation of CpG-A required the palindrome sequence allowing structure formation in a physiological environment. Once formed, G-tetrad-linked structures were stable even under denaturing conditions. Atomic force microscopy revealed that the tertiary structures formed by CpG-A represent nucleic acid-based nanoparticles in the size range of viruses. Similarly sized preformed polystyrene nanoparticles loaded with a CpG ODN that is otherwise weak at inducing IFN-
(CpG-B) gained the potency of CpG-A to induce IFN-
. Higher ODN uptake in PDC was not responsible for the higher IFN-
-inducing activity of CpG-A or of CpG-B-coated nanoparticles as compared with CpG-B. Based on these results we propose a model in which the spatial configuration of CpG motifs as particle is responsible for the virus-like potency of CpG-A to induce IFN-
in PDC.
Received for publication, September 21, 2004 , and in revised form, December 3, 2004.
* This study was supported in part by a grant from the Bundesministerium für Bildung und Forschung (Biofuture 0311896), Deutsche Forschungsgemeinschaft Grants HA 2780/4-1 and SFB 571, Dr. Mildred Scheel Stiftung Grant 10-2074, and a grant from the Human Science Foundation of Japan (to G. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
This work is part of the dissertation of this author at the Ludwig-Maximilians-University of Munich.
|| Financially supported by the Deutscher Akademischer Austauschdienst and Deutsche Forschungsgemeinschaft Sonderforschungsbereich 486.
¶¶ To whom correspondence should be addressed: Abteilung für Klinische Pharmakologie, Medizinische Klinik Innenstadt, Klinikum der Ludwig-Maximilians-Universität München, Ziemssenstrasse 1, 80336 München, Germany. Tel.: 49-89-5160-2331; Fax: 49-89-5160-4406; E-mail: ghartmann{at}lrz.uni-muenchen.de.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Bourquin, D. Anz, K. Zwiorek, A.-L. Lanz, S. Fuchs, S. Weigel, C. Wurzenberger, P. von der Borch, M. Golic, S. Moder, et al. Targeting CpG Oligonucleotides to the Lymph Node by Nanoparticles Elicits Efficient Antitumoral Immunity J. Immunol., September 1, 2008; 181(5): 2990 - 2998. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Knuefermann, M. Schwederski, M. Velten, P. Krings, H. Ehrentraut, M. Rudiger, O. Boehm, K. Fink, U. Dreiner, C. Grohe, et al. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9 Cardiovasc Res, April 1, 2008; 78(1): 26 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shin, T. Toy, S. Rothenfusser, N. Robson, J. Vorac, M. Dauer, M. Stuplich, S. Endres, J. Cebon, E. Maraskovsky, et al. P2Y receptor signaling regulates phenotype and IFN-{alpha} secretion of human plasmacytoid dendritic cells Blood, March 15, 2008; 111(6): 3062 - 3069. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Magnusson, R. Tobes, J. Sancho, and E. Pareja Cutting Edge: Natural DNA Repetitive Extragenic Sequences from Gram-Negative Pathogens Strongly Stimulate TLR9 J. Immunol., July 1, 2007; 179(1): 31 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Wikstrom, B. M. Meehan, M. Berg, S. Timmusk, J. Elving, L. Fuxler, M. Magnusson, G. M. Allan, F. McNeilly, and C. Fossum Structure-Dependent Modulation of Alpha Interferon Production by Porcine Circovirus 2 Oligodeoxyribonucleotide and CpG DNAs in Porcine Peripheral Blood Mononuclear Cells J. Virol., May 15, 2007; 81(10): 4919 - 4927. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Puig, A. Grajkowski, M. Boczkowska, C. Ausin, S. L. Beaucage, and D. Verthelyi Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primates Nucleic Acids Res., December 2, 2006; 34(22): 6488 - 6495. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hornung, J. Ellegast, S. Kim, K. Brzozka, A. Jung, H. Kato, H. Poeck, S. Akira, K.-K. Conzelmann, M. Schlee, et al. 5'-Triphosphate RNA Is the Ligand for RIG-I Science, November 10, 2006; 314(5801): 994 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jozefowski, T. H. Sulahian, M. Arredouani, and L. Kobzik Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides J. Leukoc. Biol., October 1, 2006; 80(4): 870 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guiducci, G. Ott, J. H. Chan, E. Damon, C. Calacsan, T. Matray, K.-D. Lee, R. L. Coffman, and F. J. Barrat Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation J. Exp. Med., August 7, 2006; 203(8): 1999 - 2008. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gursel, I. Gursel, H. S. Mostowski, and D. M. Klinman CXCL16 Influences the Nature and Specificity of CpG-Induced Immune Activation J. Immunol., August 1, 2006; 177(3): 1575 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Patole, D. Zecher, R. D. Pawar, H.-J. Grone, D. Schlondorff, and H.-J. Anders G-Rich DNA Suppresses Systemic Lupus J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3273 - 3280. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Asselin-Paturel and G. Trinchieri Production of type I interferons: plasmacytoid dendritic cells and beyond J. Exp. Med., August 15, 2005; 202(4): 461 - 465. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |